Back to Search
Start Over
Non‐discontinuation of antiseizure medication in seizure‐free epilepsy patients.
- Source :
- European Journal of Neurology; Mar2024, Vol. 31 Issue 3, p1-8, 8p
- Publication Year :
- 2024
-
Abstract
- Background and purpose: In patients with epilepsy and sustained seizure freedom, guidelines recommend considering discontinuation of antiseizure medication (ASM) based on shared decision‐making. This study aims to identify factors associated with non‐discontinuation of ASM in seizure‐free patients. Methods: Retrospective data from three sites of an academic outpatient clinic were analyzed. Adult patients with epilepsy who have been seizure‐free for ≥24 months on ASM monotherapy were included. The primary end‐point was non‐discontinuation of ASM, defined as no discontinuation or no dose reduction of ≥25% at the last outpatient clinic visit in the ultimate seizure‐free interval. Secondary end‐points included frequency of discussion on discontinuation attempts between patients and physicians, adherence to ASM discontinuation decisions, and post‐discontinuation seizure outcomes. Results: Out of 338 included patients, 81.7% did not discontinue ASM and did not reduce its dose, 11.5% discontinued ASM and 6.8% had a significant dose reduction. Factors independently associated with non‐discontinuation of ASM were history of focal to bilateral or generalized tonic–clonic seizures (odds ratio [OR] 2.33, 95% confidence interval [CI] 1.08–5.06), history of breakthrough seizures (OR 3.32, 95% CI 1.10–10.04), history of failed attempts to discontinue or reduce the ASM dose (OR 4.67, 95% CI 1.03–21.11) and higher ASM load at the index visit (OR 6.10, 95% CI 2.09–17.78). Discontinuation attempts were made during the entire period of seizure freedom and were most commonly undertaken ≥10 years after the last seizure. Conclusions: This study provides insights into factors associated with the shared decision‐making process regarding ASM discontinuation in seizure‐free patients and highlights the importance of considering individual patient characteristics and seizure history. [ABSTRACT FROM AUTHOR]
- Subjects :
- PEOPLE with epilepsy
SEIZURES (Medicine)
DRUGS
ODDS ratio
CONFIDENCE intervals
Subjects
Details
- Language :
- English
- ISSN :
- 13515101
- Volume :
- 31
- Issue :
- 3
- Database :
- Complementary Index
- Journal :
- European Journal of Neurology
- Publication Type :
- Academic Journal
- Accession number :
- 175327052
- Full Text :
- https://doi.org/10.1111/ene.16160